CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Balance Sheet
NASDAQ:CNTB • KYG235491019
Current stock price
2.47 USD
0 (0%)
At close:
2.47 USD
0 (0%)
After Hours:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 10.77M | 353.40M | 1.65B | 975.80M | |||
| Cash Equivalents | 78.23M | 105.66M | 196.90M | 60.90M | 34.30M | |||
| Marketable Securities | 15.48M | 12.64M | 511.30M | 0.00 | 13.10M | |||
| Receivables | 1.05M | 351.00K | N/A | N/A | N/A | |||
| Other Current Assets | 2.20M | 3.90M | 23.40M | 47.20M | 33.60M | |||
| Total Current Assets | 96.96M | 122.55M | 1.08B | 1.75B | 1.06B | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.24M | 4.74M | 59.00M | 82.20M | 7.90M | |||
| Investments And Advances | N/A | 0.00 | 65.70M | N/A | N/A | |||
| Intangibles | 53.00K | 62.00K | 500.00K | 600.00K | 300.00K | |||
| Other Non-Current Assets | 33.00K | 24.00K | 600.00K | 800.00K | 9.60M | |||
| Total Non-Current Assets | 4.32M | 4.82M | 127.00M | 101.60M | 28.10M | |||
| TOTAL ASSETS | 101.28M | 127.38M | 1.21B | 1.86B | 1.08B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 285.00K | 1.30M | 600.00K | 600.00K | |||
| Accrued Expenses | 7.96M | 9.76M | 20.70M | 13.70M | 12.20M | |||
| Accounts Payable | 342.00K | 2.21M | 83.10M | 81.20M | 24.60M | |||
| Other Current Liabilities | 164.00K | 13.32M | 3.70M | 19.10M | 500.00K | |||
| Total Current Liabilities | 8.46M | 25.29M | 108.80M | 114.70M | 38.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 1.70M | 200.00K | 2.07B | |||
| Other Non-Current Liabilities | 656.00K | 585.00K | 4.50M | 5.00M | N/A | |||
| Total Non-Current Liabilities | 656.00K | 585.00K | 6.30M | 5.10M | 2.07B | |||
| TOTAL LIABILITIES | 9.12M | 25.88M | 115.10M | 119.80M | 2.11B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -345.36M | -329.73M | -3.07B | -2.32B | -1.06B | |||
| Additional Paid In Capital | 439.36M | 432.40M | 4.09B | 4.09B | 41.50M | |||
| Common Shares | 10.00K | 10.00K | 100.00K | 100.00K | 0.00 | |||
| Treasury Stock | -180.00K | -180.00K | -1.20M | -1.20M | 0.00 | |||
| Other Shareholders' Equity | -1.67M | -1.01M | 71.10M | -41.20M | -1.70M | |||
| Shares Outstanding | 55.00M | 54.76M | 57.09M | 57.14M | 55.45M | |||
| Tangible Book Value per Share | 1.66 | 1.84 | 19.09 | 30.18 | -18.37 | |||
| Total Shareholders' Equity | 92.17M | 101.50M | 1.10B | 1.74B | -1.02B | |||
| TOTAL LIABILITIES AND EQUITY | 101.28M | 127.38M | 1.21B | 1.86B | 1.08B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.00 | 0.00 | -2.02 | |||
| Current Ratio | 11.46 | 4.85 | 9.97 | 15.29 | 27.81 | |||
| Return On Assets (ROA) | -15.43% | -48.76% | -65.77% | -70.42% | -71.83% | |||
| Return On Equity (ROE) | -16.96% | -61.19% | -72.66% | -75.29% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21